USPTO serial 87828203
DXLAB
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROSS, TRACY L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DXLAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pamela B. Huff
Pamela B. Huff Schwegman Lundberg & Woessner, P.A.P.O. Box 2938Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for clinical or medical laboratory use; Reagents in test containers, canisters, panels and microtitre plates for clinical and medical laboratory use | ACTIVE | — |
| 005 | Antibiotics in test containers, canisters, panels and microtitre plates for clinical and medical laboratory use; medical diagnostic assays for testing of body fluids; chemical preparations, namely, chemical reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes; chemicals and diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; immunoassay test kits for medical use consisting primarily of in vitro reagents for the diagnosis and monitoring of physiological significance | ACTIVE | — |
| 009 | Laboratory equipment, namely, automated sample handling equipment, clinical laboratory analyzers, chemistry analyzers and operating software for use therewith, all in the field of scientific and laboratory use; laboratory equipment and supplies, namely, pipette tips, test tubes, test tube racks, centrifuge tube racks, and laboratory wetting trays; clinical laboratory computer software used to receive orders for laboratory testing and assist medical technologists with managing the testing of patient and quality control samples on instruments; computer software for use with clinical diagnostic and microbiology instruments used to analyze and interpret data and generate printed reports; computer software for monitoring drug levels in biological fluids; computerized apparatus for clinical laboratory and microbiology use, namely, chemical and micro-organism analyzers; laboratory apparatus, namely, reagent bottles sold empty, reagent holding trays, funnels, droppers, dropper caps and waste bags; laboratory apparatus, namely, rehydrator and inoculator devices for rehydrating and inoculating multiple wells with inoculum liquids for in vitro diagnostic use; instruments, systems, equipment and devices for laboratory, biotechnology, bioresearch, biomedical and clinical diagnosis research, namely, hematology and blood analyzers; automated microbiology analyzers for clinical laboratory use; automated hematology chemistry analyzers for clinical laboratory use; laboratory equipment, namely, automated biological testing sample handling apparatus, clinical laboratory analyzers for scientific and laboratory use for measuring, testing and analyzing blood and other bodily fluids, and chemistry analyzers for use therewith | ACTIVE | — |
| 010 | Medical and laboratory diagnostic equipment, namely, clinical laboratory analyzers, chemistry analyzers, and automated sample handling equipment, all for medical use; Clinical diagnostic instruments for use in automated microbial identification and susceptibility testing, for medical use; plastic tubes for the collection and centrifugation of blood samples, for medical use; hematology analyzers for medical diagnostic uses; sample preparation device for medical diagnostic uses; automated microbiology analyzers for medical diagnostic use; automated hematology chemistry analyzers for medical diagnostic uses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Beckman Coulter, Inc.
- Other trademarks owned by Beckman Coulter, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named DXLAB
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 13, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 8, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 8, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 4, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 17, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 15, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 15, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 15, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 7, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 5, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 5, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 6, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 4, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 7, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 7, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 7, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 3, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 17, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 16, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2018 | NWAP | NEW APPLICATION ENTERED | — |